Want to join the conversation?
$JNJ said its Janssen Research & Development unit has submitted a supplemental New Drug Application for ibrutinib to the US FDA for the treatment of patients with marginal zone lymphoma who require systemic therapy. Marginal zone lymphoma affects the white blood cells. The filing is based on data from the Phase 2 PCYC-1121 trial.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.
$FHN shares have dropped after its earnings missed analysts’ expectations. I’m worried whether the stock will slide further.